News
2024.05.29
Oncovita and the Institut Pasteur have already been working together for several years on the construction and development of new vaccines based on MeasovirR...
News
2023.11.27
Oncovita, a spin-off from the Institut Pasteur, has won the call for projects "Innovation in biotherapies and bioproduction" as part of the France 2030...